CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
At 25, knowing what to look for in a financial advisor can set the foundation for your future. Focus on experience, fees, and communication.
21,157 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
A small-cap memory-interface provider, Lumina IP, reports gross margins near 80% in Q1 2026 as AI accelerators push d...
U.S. investors will soon access perpetual futures, a cornerstone of the hottest crypto products world, under a new re...
As lawmakers push a sweeping crypto regulation bill, the former president's outspoken support for digital assets is c...
A little-known U.S.-Canada totalization treaty lets cross-border workers pool credits for retirement, but missteps in...
A single indicator could steer the next 12 months for the iShares 20+ Year Treasury Bond ETF (TLT). If the 30-year yi...
A top cybersecurity name rides a durable, AI-driven megatrend, signaling decades of demand as enterprises simplify an...
Markets remain choppy as 2026 unfolds. This article lays out practical steps to shield portfolios and stay resilient ...
GameStop reports a record quarterly profit and unveils a $2 billion buyback while the eBay bid battle heats up, marki...
The ripple (xrp) price down narrative dominates crypto desks as XRP slides toward $1 amid a market-wide pullback. Her...
XRP traded near the $0.60 mark as the broader crypto market declined, with Ripple expanding partnerships and pushing ...
A micro-tour cash ripple shows how hype drives real spending. This piece weighs those signals against World Cup forec...